Search

Your search keyword '"Tranexamic acid -- Intellectual property"' showing total 80 results
Start Over Descriptor "Tranexamic acid -- Intellectual property"
80 results on '"Tranexamic acid -- Intellectual property"'

2. Patent Issued for Polymer agonists of mu opioid receptors (USPTO 12037416)

Subjects
Intellectual property, Physical fitness, Amino acids -- Intellectual property, Polymers -- Intellectual property, Tranexamic acid -- Intellectual property
Abstract

2024 AUG 10 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- A patent by the inventors Hamsher, James (Darien, CT, US), Maglaris, Constantine [...]

Published
2024

3. Patent Issued for Apparatus for forming delivery path for composition for treatment and auxiliary assembly for skin treatment including same (USPTO 11980733)

Subjects
Intellectual property, Physical fitness, Skin care products -- Intellectual property, Skin, Tranexamic acid -- Intellectual property
Abstract

2024 JUN 8 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Lutronic Corporation (Goyang, South Korea) has been issued patent number 11980733, according [...]

Published
2024

4. Researchers Submit Patent Application, 'Active Agent-Releasing Hyaluronic Acid Vehicle', for Approval (USPTO 20240139233)

Subjects
Intellectual property, Physical fitness, Tranexamic acid -- Intellectual property, Fluocinolone, Hyaluronic acid -- Intellectual property, Fluocinolone acetonide
Abstract

2024 MAY 25 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- From Washington, D.C., NewsRx journalists report that a patent application by the [...]

Published
2024

5. Patent Issued for Tissue factor pathway inhibitor antibodies and uses thereof (USPTO 12168698)

Subjects
Novo Nordisk A/S -- Intellectual property, Intellectual property, Amino acids -- Intellectual property, Factor VII -- Intellectual property, Antibodies, Tranexamic acid -- Intellectual property, Biological products -- Intellectual property, Viral antibodies, Blood coagulation factors -- Intellectual property
Abstract

2025 JAN 6 (NewsRx) -- By a News Reporter-Staff News Editor at Hematology Week -- According to news reporting originating from Alexandria, Virginia, by NewsRx journalists, a patent by the [...]

Published
2025

6. Patent Issued for Synthetic platelets (USPTO 12161698)

Subjects
Intellectual property, Factor VII -- Intellectual property, Tranexamic acid -- Intellectual property, Blood coagulation factors -- Intellectual property
Abstract

2024 DEC 30 (NewsRx) -- By a News Reporter-Staff News Editor at Cardiovascular Week -- A patent by the inventors Pawloski, Christa (Seven Hills, OH, US), Sen Gupta, Anirban (Cleveland, [...]

Published
2024

7. Patent Application Titled 'Utility Of Vitamin D, Folic Acid And Nadh To Improve Ligament Injury Prevention Characteristics' Published Online (USPTO 20240398819)

Subjects
Intellectual property, Injuries, Raltegravir -- Intellectual property, Paricalcitol, Miglustat, Doxercalciferol, Sapropterin, Mupirocin -- Intellectual property, Folic acid -- Intellectual property, Zoledronic acid, Penciclovir -- Intellectual property, Palonosetron -- Intellectual property, Isoetharine -- Intellectual property, Droperidol, Treprostinil -- Intellectual property, Midodrine -- Intellectual property, Tezacaftor -- Intellectual property, Mangafodipir -- Intellectual property, Pentagastrin, Nitisinone -- Intellectual property, Cetrorelix -- Intellectual property, Pralatrexate, Tranexamic acid -- Intellectual property, Sapropterin dihydrochloride
Abstract

2024 DEC 27 (NewsRx) -- By a News Reporter-Staff News Editor at Health & Medicine Week -- According to news reporting originating from Washington, D.C., by NewsRx journalists, a patent [...]

Published
2024

8. Patent Issued for Polymer agonists of mu opioid receptors (USPTO 12146002)

Subjects
Intellectual property, Amino acids -- Intellectual property, Polymers -- Intellectual property, Tranexamic acid -- Intellectual property
Abstract

2024 DEC 13 (NewsRx) -- By a News Reporter-Staff News Editor at Medical Patent Business Week -- Cytogel Pharma LLC (Darien, Connecticut, United States) has been issued patent number 12146002, [...]

Published
2024

9. Patent Issued for Oral combination drug formulation comprising a non-steroidal anti-inflammatory drug and a complementary low dose of tranexamic acid for the treatment of menstrual pain accompanied with excessive menstrual blood loss (USPTO 11833126)

Subjects
Women -- Health aspects, Tranexamic acid -- Intellectual property, Nonsteroidal anti-inflammatory drugs, Amino acids -- Intellectual property, Menstruation, Pain -- Care and treatment, Health, Women's issues/gender studies, Lysteda (Medication) -- Intellectual property
Abstract

2023 DEC 28 (NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- From Alexandria, Virginia, NewsRx journalists report that a patent by the inventors Rubin, Arkady [...]

Published
2023

10. Researchers Submit Patent Application, 'Prolyl Hydroxylase Domain Inhibitor For Treating Hemorrhagic Or Burn Shock', for Approval (USPTO 20250041302)

Subjects
Medical equipment -- Intellectual property, Tranexamic acid -- Intellectual property, Icatibant, Aprotinin, Physiological apparatus -- Intellectual property, Health, Health care industry
Abstract

2025 MAR 2 (NewsRx) -- By a News Reporter-Staff News Editor at Medical Devices & Surgical Technology Week -- From Washington, D.C., NewsRx journalists report that a patent application by [...]

Published
2025

11. Patent Issued for Tranexamic acid oral solution (USPTO 11666532)

Subjects
Intellectual property, Physical fitness, Oral drugs -- Intellectual property, Tranexamic acid -- Intellectual property, Oral medication -- Intellectual property
Abstract

2023 JUL 1 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Hyloris Developments SA (Liege, Belgium) has been issued patent number 11666532, according [...]

Published
2023

13. Researchers Submit Patent Application, 'Administration Of Serine Protease Inhibitors To The Stomach', for Approval (USPTO 20220370389)

Subjects
Intellectual property, Physical fitness, Protease inhibitors -- Intellectual property, Amino acids -- Intellectual property, Tranexamic acid -- Intellectual property, Shock
Abstract

2022 DEC 17 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- From Washington, D.C., NewsRx journalists report that a patent application by the [...]

Published
2022

14. Patent Application Titled 'Prolyl Hydroxylase Domain Inhibitor Treatment To Improve Survivability Of Hemorrhagic Shock' Published Online (USPTO 20240122987)

Subjects
Intellectual property, Aprotinin, Medical equipment -- Intellectual property, Tranexamic acid -- Intellectual property, Icatibant, Physiological apparatus -- Intellectual property
Abstract

2024 MAY 12 (NewsRx) -- By a News Reporter-Staff News Editor at Medical Devices & Surgical Technology Week -- According to news reporting originating from Washington, D.C., by NewsRx journalists, [...]

Published
2024

15. Researchers Submit Patent Application, 'Platelet Derivatives For Treating Coagulopathy', for Approval (USPTO 20240066065)

Subjects
Intellectual property, Aprotinin, Anticoagulants, Factor VII -- Intellectual property, Tranexamic acid -- Intellectual property, Anticoagulants (Medicine), Blood coagulation factors -- Intellectual property
Abstract

2024 MAR 18 (NewsRx) -- By a News Reporter-Staff News Editor at Cardiovascular Week -- From Washington, D.C., NewsRx journalists report that a patent application by the inventors DICKERSON, William [...]

Published
2024

16. Patent Issued for Administration of serine protease inhibitors to the stomach (USPTO 11439611)

Subjects
Intellectual property, Physical fitness, Protease inhibitors -- Intellectual property, Amino acids -- Intellectual property, Tranexamic acid -- Intellectual property, Shock
Abstract

2022 OCT 8 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- A patent by the inventors Lee, Yung-Tsai (Andrew) (Taipei, TW), Schmid-Schonbein, Geert [...]

Published
2022

18. Patent Application Titled 'Compositions Of Hydroxy Acids With Salicylic Acid And Uses Therefore' Published Online (USPTO 20220249519)

Subjects
Intellectual property, Physical fitness, Amino acids -- Intellectual property, Tranexamic acid -- Intellectual property, Phenols (Class of compounds) -- Intellectual property, Phenols -- Intellectual property
Abstract

2022 SEP 3 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- According to news reporting originating from Washington, D.C., by NewsRx journalists, a [...]

Published
2022

20. Patent Issued for Oral combination drug formulation comprising a non-steroidal anti-inflammatory drug and a complementary low dose of tranexamic acid for the treatment of menstrual pain accompanied with excessive menstrual blood loss (USPTO 11351132)

Subjects
Tranexamic acid -- Intellectual property, Meclofenamate -- Intellectual property, Amino acids -- Intellectual property, Menstruation, Pain -- Care and treatment, Health, Women's issues/gender studies, Lysteda (Medication) -- Intellectual property
Abstract

2022 JUN 30 (NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- Arstat Inc. (Flemington, New Jersey, United States) has been issued patent number 11351132, according [...]

Published
2022

21. Patent Issued for Prefilled disposable injection device (USPTO 11878158)

Subjects
Intellectual property, Vaccines -- Intellectual property, BCG -- Intellectual property, Fosphenytoin -- Intellectual property, Dimercaprol, Tranexamic acid -- Intellectual property, Succinylcholine -- Intellectual property, BCG vaccines -- Intellectual property
Abstract

2024 FEB 14 (NewsRx) -- By a News Reporter-Staff News Editor at Vaccine Weekly -- A patent by the inventors Basile, Peter A. (Bloomsbury, NJ, US), Britland, Brad (Lake Hopatcong, [...]

Published
2024

22. 'Tranexamic Acid Oral Solution' in Patent Application Approval Process (USPTO 20240024235)

Subjects
Intellectual property, Amino acids -- Intellectual property, Oral drugs -- Intellectual property, Tranexamic acid -- Intellectual property, Oral medication -- Intellectual property
Abstract

2024 FEB 12 (NewsRx) -- By a News Reporter-Staff News Editor at Hematology Week -- A patent application by the inventors Alkhalili, Mohammad (North Richland Hills, TX, US); Bruce, L. [...]

Published
2024

24. Patent Issued for Method of administration and treatment (USPTO 11793830)

Subjects
Intellectual property, Tranexamic acid -- Intellectual property
Abstract

2023 NOV 14 (NewsRx) -- By a News Reporter-Staff News Editor at Cancer Weekly -- Dyve Biosciences Inc. (Camarillo, California, United States) has been issued patent number 11793830, according to [...]

Published
2023

26. Patent Application Titled 'Thrombosomes As An Antiplatelet Agent Reversal Agent' Published Online (USPTO 20230285465)

Subjects
Intellectual property, Aprotinin, Platelet aggregation inhibitors -- Intellectual property, Vorapaxar, Tranexamic acid -- Intellectual property, Blood platelets -- Aggregation
Abstract

2023 OCT 2 (NewsRx) -- By a News Reporter-Staff News Editor at Cardiovascular Week -- According to news reporting originating from Washington, D.C., by NewsRx journalists, a patent application by [...]

Published
2023

28. 'Reduction Of Cytokine Storm And Pathological Inflammation Including Caused By Coronavirus Using Sphagnum And Extracts Thereof' in Patent Application Approval Process (USPTO 20230165918)

Subjects
Intellectual property, Storm damage, Coronaviruses, Monoclonal antibodies, Acalabrutinib -- Intellectual property, COVID-19, Ciclesonide, Sargramostim, Vedolizumab, Cytokines, Dapagliflozin, Tranexamic acid -- Intellectual property, Everolimus, Antiarthritic agents -- Intellectual property
Abstract

2023 JUN 19 (NewsRx) -- By a News Reporter-Staff News Editor at Biotech Business Week -- A patent application by the inventors ICHIM, Thomas (San Diego, CA, US); O'HEERON, Pete [...]

Published
2023

29. 'High Concentrated Protein Compositions For Preventing Tissue Adhesion' in Patent Application Approval Process (USPTO 20230158119)

Subjects
Prevention, Intellectual property, Aprotinin, EDTA -- Intellectual property, Tranexamic acid -- Intellectual property, Ethylenediaminetetraacetic acid -- Intellectual property
Abstract

2023 JUN 16 (NewsRx) -- By a News Reporter-Staff News Editor at Medical Patent Business Week -- A patent application by the inventors EAVRI, RONEN (Binyamina, IL); GAHALI-SASS, INBAR (Mazkeret [...]

Published
2023

30. Patent Application Titled 'Adaptive Transdermal Iontophoretic Introduction System For Beauty Field' Published Online (USPTO 20210121690)

Subjects
Intellectual property, Physical fitness, Transdermal drug delivery systems -- Intellectual property, Tranexamic acid -- Intellectual property, Transdermal medication -- Intellectual property
Abstract

2021 MAY 22 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- According to news reporting originating from Washington, D.C., by NewsRx journalists, a [...]

Published
2021

32. 'Administration Of Serine Protease Inhibitors To The Stomach' in Patent Application Approval Process (USPTO 20200246291)

Subjects
Intellectual property, Physical fitness, Protease inhibitors -- Intellectual property, Amino acids -- Intellectual property, Proteases -- Intellectual property, Tranexamic acid -- Intellectual property, Shock
Abstract

2020 AUG 29 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- A patent application by the inventors Schmid-Schonbein, Geert W. (Del Mar, CA); [...]

Published
2020

33. Patent Issued for Oral Combination Drug Formulation Comprising A Non-Steroidal Anti-Inflammatory Drug And A Complementary Low Dose Of Tranexamic Acid For The Treatment Of Menstrual Pain Accompanied With Excessive Menstrual Blood Loss (USPTO 10,709,679)

Subjects
Menstruation, Amino acids -- Intellectual property, Pain management, Tranexamic acid -- Intellectual property, Meclofenamate -- Intellectual property, Health, Women's issues/gender studies, Lysteda (Medication) -- Intellectual property
Abstract

2020 JUL 30 (NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- Arstat Inc. (Flemington, New Jersey, United States) has been issued patent number 10,709,679, according [...]

Published
2020

34. Patent Issued for Patch-Type Wound Dressing Comprising Methylene Blue Mixture For Treating Skin Wound (USPTO 10,695,300)

Subjects
Intellectual property, Physical fitness, Skin, Methylene blue -- Intellectual property, Tranexamic acid -- Intellectual property, Software patches
Abstract

2020 JUL 18 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- According to news reporting originating from Alexandria, Virginia, by NewsRx journalists, a [...]

Published
2020

35. Patent Issued for Medical Wound Covering Employing Electrical Stimulation To Control Blood Flow (USPTO 10,646,710)

Subjects
Intellectual property, Physical fitness, Bupivacaine -- Intellectual property, Tranexamic acid -- Intellectual property, Blood flow, Obesity, Editors
Abstract

2020 MAY 30 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Feinstein Patents LLC (Wilkes-Barre, Pennsylvania, United States) has been issued patent number [...]

Published
2020

36. Patent Application Titled 'Apparatus For Forming Delivery Path For Composition For Treatment And Auxiliary Assembly For Skin Treatment Including Same' Published Online (USPTO 20200139096)

Subjects
Intellectual property, Physical fitness, Skin, Skin care products -- Intellectual property, Tranexamic acid -- Intellectual property, Obesity, Editors
Abstract

2020 MAY 30 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- According to news reporting originating from Washington, D.C., by NewsRx journalists, a [...]

Published
2020

38. Shilpa Medicare gets CDSCO approval for hemostatic spray of Tranexamic Acid

Subjects
Tranexamic acid -- Intellectual property, Medicare -- Intellectual property, Business, international
Abstract

The product is protected by granted patents in India till 2037 and in US, Australia, Russia and South Africa till 2038 Shilpa Medicare has received CDSCO approval for its successful [...]

Published
2022

39. Researchers Submit Patent Application, 'Plasma Kallikrein Inhibitors And Uses Thereof For Treating Hereditary Angioedema Attack', for Approval (USPTO 20230104754)

Subjects
Takeda Pharmaceutical Company Ltd. -- Intellectual property, Intellectual property, Angioneurotic edema, Lanadelumab -- Intellectual property, Kallikrein, Ecallantide, Pharmaceutical industry -- Intellectual property, Tranexamic acid -- Intellectual property, Icatibant
Abstract

2023 APR 24 (NewsRx) -- By a News Reporter-Staff News Editor at Cardiovascular Week -- From Washington, D.C., NewsRx journalists report that a patent application by the inventors Hao, Xinming [...]

Published
2023

40. Patent Application Titled 'Glutathione-Containing Composition' Published Online (USPTO 20230049576)

Subjects
Shiseido Company Ltd. -- Intellectual property, Intellectual property, Skin, Thiols -- Intellectual property, Tranexamic acid -- Intellectual property, Cosmetics industry -- Intellectual property
Abstract

2023 MAR 6 (NewsRx) -- By a News Reporter-Staff News Editor at Hematology Week -- According to news reporting originating from Washington, D.C., by NewsRx journalists, a patent application by [...]

Published
2023

41. Patent Application Titled 'Treating Bleeding And Bleeding Disorders Via High Intensity Focused Ultrasound Stimulation Of The Spleen' Published Online (USPTO 20230019961)

Subjects
Intellectual property, Factor VII -- Intellectual property, Tranexamic acid -- Intellectual property, Hematologic diseases, Blood diseases, Blood coagulation factors -- Intellectual property
Abstract

2023 FEB 6 (NewsRx) -- By a News Reporter-Staff News Editor at Hematology Week -- According to news reporting originating from Washington, D.C., by NewsRx journalists, a patent application by [...]

Published
2023

42. Researchers Submit Patent Application, 'Swellable Polymer Hybrid Fibres For A Sleeve Of An Intraluminal Endoprosthesis', for Approval (USPTO 20230009211)

Subjects
Intellectual property, Aprotinin, EDTA -- Intellectual property, Polymers -- Intellectual property, Tranexamic acid -- Intellectual property, Everolimus, Ethylenediaminetetraacetic acid -- Intellectual property
Abstract

2023 FEB 3 (NewsRx) -- By a News Reporter-Staff News Editor at Medical Patent Business Week -- From Washington, D.C., NewsRx journalists report that a patent application by the inventors [...]

Published
2023

43. Patent Issued for Phosphonium-based ionic drug conjugates (USPTO 11541120)

Subjects
Intellectual property, Fenoprofen -- Intellectual property, Antihypertensive agents, Angiotensin II receptor blockers, Eplerenone, Therapeutics -- Intellectual property, Antilipemic agents -- Intellectual property, Alitretinoin -- Intellectual property, Cefditoren -- Intellectual property, Obeticholic acid -- Intellectual property, Decitabine, Angiotensin converting enzyme inhibitors, Fenofibrate -- Intellectual property, Clopidogrel -- Intellectual property, Nisoldipine -- Intellectual property, Emtricitabine -- Intellectual property, Adefovir dipivoxil -- Intellectual property, Elvitegravir, Esmolol -- Intellectual property, Tranexamic acid -- Intellectual property, Antineoplastic agents -- Intellectual property, Tirofiban -- Intellectual property, Homeopathy -- Materia medica and therapeutics, Antimitotic agents -- Intellectual property, ACE inhibitors, Antihypertensive drugs
Abstract

2023 JAN 23 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity & Diabetes Week -- From Alexandria, Virginia, NewsRx journalists report that a patent by the inventors Kalaritis, [...]

Published
2023

44. Patent Issued for Oral Combination Drug Formulation Comprising A Non-Steroidal Anti-Inflammatory Drug And A Complementary Low Dose Of Tranexamic Acid For The Treatment Of Menstrual Pain Accompanied With Excessive Menstrual Blood Loss (USPTO 10,532,037)

Subjects
Menstruation, Amino acids -- Intellectual property, Pain management, Tranexamic acid -- Intellectual property, Meclofenamate -- Intellectual property, Allergy, Anti-inflammatory agents, Nonsteroidal anti-inflammatory agents, Women's health, Hemostatic agents, Health, Editors, Health, Women's issues/gender studies, Lysteda (Medication) -- Intellectual property
Abstract

2020 JAN 30 (NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- A patent by the inventor Rubin, Arkady (Flemington, NJ), filed on March 5, 2019, [...]

Published
2020

45. Patent Issued for RNA Complexes That Inhibit Melanin Production (USPTO 10,512,600)

Subjects
Intellectual property, Physical fitness, Free radicals, Tranexamic acid -- Intellectual property, RNA, Obesity, Anopheles, Editors
Abstract

2020 JAN 11 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- A patent by the inventors Hong, Sun Woo (Seoul, KR); Hong, Isu [...]

Published
2020

46. Patent Application Titled 'Preparation Of Microparticles Of An Active Ingredient' Published Online (USPTO 20190380967)

Subjects
Intellectual property, Oxprenolol -- Intellectual property, Ticarcillin -- Intellectual property, Hypoglycemic agents, Milnacipran, Amino acids -- Intellectual property, Amoxapine -- Intellectual property, Levorphanol -- Intellectual property, Cefmetazole -- Intellectual property, Methdilazine -- Intellectual property, Oxazepam -- Intellectual property, Terbutaline -- Intellectual property, Methimazole -- Intellectual property, Physical fitness, Tubocurarine, Oxytetracycline -- Intellectual property, Nebivolol, Tranexamic acid -- Intellectual property, Dulaglutide, Paliperidone, Semaglutide -- Intellectual property, Flurazepam -- Intellectual property, Tetracyclines, Lixisenatide, Liraglutide, Obesity, Exenatide, Editors, Disclosure of information, Albiglutide
Abstract

2020 JAN 11 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- According to news reporting originating from Washington, D.C., by NewsRx journalists, a [...]

Published
2020

47. Researchers Submit Patent Application, 'Medical Wound Covering Employing Electrical Stimulation To Control Blood Flow', for Approval (USPTO 20190366083)

Subjects
Intellectual property, Physical fitness, Bupivacaine -- Intellectual property, Tranexamic acid -- Intellectual property, Blood flow, Obesity, Editors, Patents
Abstract

2019 DEC 28 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- From Washington, D.C., NewsRx journalists report that a patent application by the [...]

Published
2019

49. Researchers Submit Patent Application, 'Patch-Type Wound Dressing Comprising Methylene Blue Mixture For Treating Skin Wound', for Approval (USPTO 20190224134)

Subjects
Intellectual property, Physical fitness, Transdermal drug delivery systems -- Intellectual property, Skin, Methylene blue -- Intellectual property, Tranexamic acid -- Intellectual property, Obesity, Disclosure of information, Editors
Abstract

2019 AUG 17 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- From Washington, D.C., NewsRx journalists report that a patent application by the [...]

Published
2019

50. 'Tranexamic Acid Oral Solution' in Patent Application Approval Process (USPTO 20190224121)

Subjects
Intellectual property, Physical fitness, Amino acids -- Intellectual property, Tranexamic acid -- Intellectual property, Oral drugs -- Intellectual property, Obesity, Hemostatic agents, Editors
Abstract

2019 AUG 17 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- A patent application by the inventors Erstad, Mary Beth G. (Plymouth, MN); [...]

Published
2019

Catalog

Books, media, physical & digital resources
See catalog results